TANOREN 0.5 mg/ml, solution for dilution for solution for injection/for infusion 10 ampoules of 2 ml
Active ingredients: Norepinephrine, Norepinephrine bitartrate monohydrate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for dilution for injection or infusion10 ampoules of 2 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TANOREN 0,5 mg/mL, solution à diluer pour solution injectable/pour perfusion
- Pharmaceutical form
- solution à diluer pour injection ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 ampoules en verre de 2 mL
- Marketing authorisation holder
- LABORATOIRE RENAUDIN
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Oct 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60743407CIP75510630CIP133400955106302Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TARTRATE DE NORADRÉNALINEsolution | 0,5 mg · un 1 mL de solution à diluer | SA |
| NORADRÉNALINEsolution | 0,25 mg · un 1 mL de solution à diluer | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.